Valeant Reportedly Nearing Deal To Buy Bausch & Lomb For $9 Bln
Valeant Reportedly Nearing Deal To Buy Bausch & Lomb For $9 Bln NASDAQ
View ArticleValeant pays $8.7 billion for Bausch & Lomb
Valeant pays $8.7 billion for Bausch & Lomb CNN Money
View ArticleValeant: FDA Rejects Nail Fungus Treatment Efinaconazole Over Container
Valeant: FDA Rejects Nail Fungus Treatment Efinaconazole Over Container FOX Business
View ArticleValeant, Bausch & Lomb And The Long Reach Of Fred Hassan
Valeant, Bausch & Lomb And The Long Reach Of Fred Hassan Pharmalot
View Article5 Drugs Stocks Driving The Industry Higher
5 Drugs Stocks Driving The Industry Higher TheStreet.com
View ArticleChina Biotech In Review: Valeant Pharma Gains Sales Foothold In China With...
China Biotech In Review: Valeant Pharma Gains Sales Foothold In China With Bausch & Lomb Buy Seeking Alpha
View ArticleZogenix and Valeant Pharmaceuticals Enter Exclusive Co-Promotion Agreement...
Zogenix and Valeant Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Migranal(R) Nasal Spray Yahoo
View ArticleValeant To Cut To 2,850 Workers After Bausch + Lomb Deal
Valeant To Cut To 2,850 Workers After Bausch + Lomb Deal Pharmalot
View ArticleValeant CEO Blasted By NY Pols For Moving Bausch + Lomb HQ
Valeant CEO Blasted By NY Pols For Moving Bausch + Lomb HQ Pharmalot
View ArticleValeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch +...
Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch + Lomb Yahoo
View ArticleWhich are pharma's top 4 innovators? Hint: It's not the big guys
Which are pharma's top 4 innovators? Hint: It's not the big guys Fierce Pharma
View ArticleAnacor: Overvalued On Weak Drug Pipeline
Anacor: Overvalued On Weak Drug Pipeline TheStreet.com
View ArticleValeant Pharmaceuticals Seeks to Cut Rates on $2.3 Billion Loans
Valeant Pharmaceuticals Seeks to Cut Rates on $2.3 Billion Loans Bloomberg/Businessweek
View ArticleActavis, Gilead, Valeant: Outlook For Health Stocks
Actavis, Gilead, Valeant: Outlook For Health Stocks Investors.com
View ArticleWith $29B in deals so far, 2013 shaping up as big M&A year
With $29B in deals so far, 2013 shaping up as big M&A year Fierce Pharma
View ArticleAnacor reaches all-time high after saying it got $100M arbitration ruling in...
Anacor reaches all-time high after saying it got $100M arbitration ruling in Valeant dispute Yahoo/AP
View ArticleCanada's Valeant posts loss, cuts 2013 sales forecast
Canada's Valeant posts loss, cuts 2013 sales forecast Yahoo/Reuters
View ArticleDrug-maker Valeant eyes small and large M&A deals
Drug-maker Valeant eyes small and large M&A deals Reuters
View ArticleEndo Tax Edge for Deals Mimics Valeant Playbook: Real M&A
Endo Tax Edge for Deals Mimics Valeant Playbook: Real M&A Bloomberg
View Article